Dr Koo on PSMA PET Imaging in Prostate Cancer
Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.
Stay updated with breaking news from Psma Pet. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Phillip J. Koo, MD, discusses the use of PSMA PET imaging in prostate cancer.
University of California prostate cancer experts will share clinical insights at the first annual PSMA Conference, “PSMA PET and RLT: Present and Future.”
PURPOSE: This study aimed to determine the viability of focal dose escalation to prostate cancer intraprostatic lesions (IPLs) from multiparametric magnetic resonance (mpMRI) and prostate-specific membrane antigen positron emission tomography (PSMA-PET) images using high-dose-rate (HDR) prostate brachytherapy (pBT). METHODS AND MATERIALS: Retrospective data from 20 patients treated with HDR pBT was utilized. The interobserver contouring variability of 5 observers was quantified using the dice similarity coefficient (DSC) and mean distance to agreement (MDA). Uncertainty in propagating IPL cont...
MyJournals.org - Science - 'Redefining 18F DCFPyl PSMA‐PET detected local recurrence from radical prostatectomy histopathology' (BJU International)
Expert oncologists provide a focused review on goals of therapy for patients with non-metastatic castration-resistant prostate cancer (nmCRPC).